NOPHO-DBH AML 2012 Protocol Research study for treatment of children and adolescents with acute myeloid leukaemia 0-18 years NOPHO-DBH AML 2012 protokoll. Forskningsstudie för behandling av barn och ungdomar med akut myeloisk leukemi 0-18 år.

Trial Profile

NOPHO-DBH AML 2012 Protocol Research study for treatment of children and adolescents with acute myeloid leukaemia 0-18 years NOPHO-DBH AML 2012 protokoll. Forskningsstudie för behandling av barn och ungdomar med akut myeloisk leukemi 0-18 år.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 19 Mar 2017

At a glance

  • Drugs Daunorubicin (Primary) ; Fludarabine (Primary) ; Cytarabine; Etoposide; Mitoxantrone
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 15 Apr 2013 New source identified and integrated: ClinicalTrials.gov record.
    • 23 Feb 2013 Additional lead trial centres identified as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top